Select Publications
Conference Papers
2016, 'DIFFERENCES IN RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE-MEDIATED NEUROPATHY: THE IMPORTANCE OF CONDUCTION BLOCK', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, SCOTLAND, Univ Glasgow, Glasgow, pp. 175 - 175, presented at Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and Ceilidh, SCOTLAND, Univ Glasgow, Glasgow, 21 June 2016 - 24 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383856200055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Spatiotemporal delineation of a cerebral photothrombotic infarct in mouse using darkfield microscopy', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, AUSTRALIA, Cairns, pp. 292 - 292, presented at 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, AUSTRALIA, Cairns, 23 August 2015 - 27 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360206300736&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Effects of neuropathy on physical function and quality of life in moderate severity chronic kidney disease', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e4 - e4, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.031
,2013, 'Insulin pump therapy in type 1 diabetes: Potential to be neuroprotective', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e1 - e2, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.024
,2012, 'PREDICTORS OF PHYSICAL PERFORMANCE IN PATIENTS ON MAINTENANCE HAEMODIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 37 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Effects of calcineurin inhibitor treatment on peripheral nerve function in renal transplant recipients', in American Journal of Transplantation, Boston, United States of America, pp. 116 - 116, presented at American Transplant Congress, Boston, United States of America, 02 June 2012 - 06 June 2012, http://dx.doi.org/10.1111/j.1600-6143.2012.04112.x
,2012, 'Evidence for a causal relationship between nerve dysfunction and hyperkalaemia in end-stage kidney disease', in Nephrology Dialysis Transplantation, Paris, France, pp. ii70 - ii72, presented at 49th Congress of the European Renal Association/European Dialysis and Transplant Association, Paris, France, 25 May 2012 - 27 May 2012, http://dx.doi.org/10.1093/ndt/gfs211
,2012, 'EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN NERVE DYSFUNCTION AND HYPERKALAEMIA IN END-STAGE KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. 70 - 70, presented at 49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), FRANCE, Paris, 24 May 2012 - 27 May 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311494700155&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Effects of Calcineurin Inhibitor Treatment on Peripheral Nerve Function in Renal Transplant Recipients', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, pp. 116 - 116, presented at American Transplant Congress, MA, Boston, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303235500304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Altered axonal excitability in asymptomatic type 1 diabetic patients', in Clinical Neurophysiology, Elsevier, Gold Coast, Queensland, pp. e73 - e73, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 02 October 2011 - 05 October 2011, http://dx.doi.org/10.1016/j.clinph.2011.11.023
,2011, 'Evidence for distinct patterns of axonal excitability between type 1 and type 2 diabetic nerves', in Journal of the Peripheral Nervous System, Wiley, Potomac, Unites States of America, pp. S5 - S5, presented at Peripheral Nerve Society Meeting, Potomac, Unites States of America, 25 September 2011 - 29 September 2011, http://dx.doi.org/10.1111/j.1529-8027.2011.00335.x
,2011, 'Pre-diabetic neuropathy: Axonal dysfunction evident prior to clinical neuropathy', in Journal of the Peripheral Nervous System, Wiley, Potomac, Unites States of America, presented at Peripheral Nerve Society Meeting, Potomac, Unites States of America, 25 September 2011 - 29 September 2011, http://dx.doi.org/10.1111/j.1529-8027.2011.00335.x
,2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S436 - S436, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71792-0
,2011, 'Neurophysiological parameters and impaired quality of life in diabetic peripheral neuropathy', Perth, presented at Australian Diabetes Society Scientific Meeting 2011, Perth, 31 August 2011
,2011, 'EVIDENCE FOR DISTINCT PATTERNS OF AXONAL EXCITABILITY BETWEEN TYPE 1 AND TYPE 2 DIABETIC NERVES', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, MD, Potomac, pp. S5 - S5, presented at Meeting of the Peripheral-Nerve-Society, MD, Potomac, 25 June 2011 - 29 June 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293510300011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'PRE DIABETIC NEUROPATHY: AXONAL DYSFUNCTION EVIDENT PRIOR TO CLINICAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, MD, Potomac, pp. S75 - S75, presented at Meeting of the Peripheral-Nerve-Society, MD, Potomac, 25 June 2011 - 29 June 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293510300164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'P4.17 Novel neurophysiological insights into uraemic neuropathy: implications for clinical trials', in Clinical Neurophysiology, Rome, Italy, pp. S75 - S75, presented at European Congress of Clinical Neurophysiology, Rome, Italy, 21 June 2011 - 25 June 2011, http://dx.doi.org/10.1016/S1388-2457(11)60256-3
,2011, 'W1.4 In vivo evidence of neurophysiological differentiation between type 1 and type 2 diabetic nerves', in Clinical Neurophysiology, Rome, Italy, pp. S7 - S7, presented at European Congress of Clinical Neurophysiology, Rome, Italy, 21 June 2011 - 25 June 2011, http://dx.doi.org/10.1016/S1388-2457(11)60021-7
,2010, 'P21-5 Sural nerve excitability: Implications for the early identification of peripheral nerve dysfunction', in Clinical Neurophysiology, Kobe, Japan, pp. S227 - S227, presented at International Congress of Clinical Neurophysiology, Kobe, Japan, 28 October 2010 - 01 November 2010, http://dx.doi.org/10.1016/S1388-2457(10)60929-7
,2010, 'URAEMIC NEUROPATHY REMAINS UBIQUITIOUS: RATIONALE AND FEASIBILITY OF THE FINESSE (FILTRATION IN THE NEUROPATHY OF END STAGE KIDNEY DISEASE SYMPTOM EVOLUTION) TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. 88 - 88, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Acute, reversible axonal energy failure during a stroke-like episode in MELAS', in Small D (ed.), 30th Annual Meeting of the Australian Neuroscience Society, Sydney, pp. 160 - 160, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
,2010, 'Pathophysiology of paclitaxel-induced neurotoxicity', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 160 - 160, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
,2010, 'Topiramate modulates axonal ion channel function in vivo.', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 -
,2009, 'Exhaled Breath Condensate Pepsin Correlates with BAL Pepsin: A Potential Marker of GERD Post Lung Transplantation?', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, FRANCE, Paris, pp. S213 - S214, presented at 29th Annual Meeting and Scientific Session of the International-Society-for-Heart-and-Lung-Transplantation, FRANCE, Paris, 22 April 2009 - 25 April 2009, http://dx.doi.org/10.1016/j.healun.2008.11.433
,2009, 'Neurotoxicity in acute intermittent porphyria - understand the madness of King George', in Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010: Leaps and Bounds, Canberra, presented at Australian Neuroscience Society 29th Annual Meeting, Canberra, 27 January 2009 - 30 January 2009
,2009, 'EFFECTS OF IMMUNOTHERAPY ON NERVE EXCITABILITY IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 89 - 90
,2009, 'INSANE IN THE MEMBRANE: ION CHANNEL DYSFUNCTION IN PORPHYRIC NEUROPATHY', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 89 - 89
,2008, 'Early detection of oxaliplatin-induced neurotoxicity: Getting it before it hurts', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.15015
,2004, 'Excitability differences of lower limb motor axons exposed to ischemia', in MUSCLE & NERVE, JOHN WILEY & SONS INC, GA, Savannah, pp. 527 - 528, presented at 51st Annual Meeting of the American-Association-of-Electrodiagnostic-Medicine (AAEM), GA, Savannah, 03 November 2004 - 06 November 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224116900057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Nerve excitability properties in uremic neuropathy', in MUSCLE & NERVE, JOHN WILEY & SONS INC, GA, Savannah, pp. 521 - 522, presented at 51st Annual Meeting of the American-Association-of-Electrodiagnostic-Medicine (AAEM), GA, Savannah, 03 November 2004 - 06 November 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224116900041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Abstracts
2020, 'THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 11 - 11
,2018, 'Poor sleep and sleep disorders are very common in people with multiple sclerosis', in JOURNAL OF SLEEP RESEARCH, WILEY, AUSTRALIA, Brisbane, Vol. 27, presented at 30th Annual Scientific Meeting (ASM) of Australasian-Sleep-Association and the Australasian-Sleep-Technologists-Association (Sleep DownUnder), AUSTRALIA, Brisbane, 17 October 2018 - 20 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446452100213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, MD, Baltimore, Vol. 23, pp. 275 - 275, presented at Annual Meeting of the Peripheral-Nerve-Society, MD, Baltimore, 21 July 2018 - 25 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000452787700066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Prevalence, impact and progression of peripheral neuropathy in early chronic kidney disease', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, MD, Baltimore, Vol. 23, pp. 382 - 382, presented at Annual Meeting of the Peripheral-Nerve-Society, MD, Baltimore, 21 July 2018 - 25 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000452787700327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'ASSOCIATION BETWEEN PERIPHERAL NERVE FUNCTION AND STRUCTURE IN HUMAN DIABETIC NERVES', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.1
,2016, 'Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?', in Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?, Elsevier, Vol. 127, pp. e13, presented at ANZAN Biennial Clinical Neurophysiology Workshop, http://dx.doi.org/10.1016/j.clinph.2015.11.029
,2015, 'Comparison of digits 2 and 3 sensory studies in patients with carpal tunnel syndrome', in Comparison of digits 2 and 3 sensory studies in patients with carpal tunnel syndrome, Sheraton Mirage Resort, Southport, Queensland, presented at 16th Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists, Sheraton Mirage Resort, Southport, Queensland, 27 September 2015 - 30 September 2015, http://dx.doi.org/10.1016/j.clinph.2015.11.033
,2015, 'Haemodialysis alters nerve morphology in chronic kidney disease', in Haemodialysis alters nerve morphology in chronic kidney disease, Sheraton Mirage Resort, Southport, Queensland, presented at 16th Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists, Sheraton Mirage Resort, Southport, Queensland, 27 September 2015 - 30 September 2015, http://dx.doi.org/10.1016/j.clinph.2015.11.034
,2006, 'Exhaled breath condensate biomarker analysis: A non-invasive diagnostic tool after lung transplantation?', in Immunology and Cell Biology, Wiley, Canberra, ACT, Vol. 84, pp. A17 - A18, presented at 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, 29 March 2006
,2006, 'Lung transplantation for COPD: Making BODE work', in Immunology and Cell Biology, Wiley, Canberra, ACT, Vol. 84, pp. A21 - A21, presented at 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, 29 March 2006
,2006, 'Pulmonary embolism: A diagnostic pitfall after lung transplantation', in Immunology and Cell Biology, Wiley, Canberra, ACT, Vol. 84, pp. A18 - A18, presented at 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, 29 March 2006
,Preprints
2024, Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes, http://dx.doi.org/10.20944/preprints202409.0511.v1
,